FDA approves Innoviva’s bacterial pneumonia treatment By: MarketWatch May 23, 2023 at 22:32 PM EDT The Food and Drug Administration said Tuesday that it approved Innoviva's Xacduro pneumonia treatment, which fights the Acinetobacter bacteria. Read More >> Related Stocks: Innoviva, Inc. - Common Stock
